The FDA warned consumers and the medical community this week about the risk of muscle damage and rhabdomyolysis from highest doses of the cholesterol drug simvastatin. The lawyers at Saiontz & Kirk, P.A. are reviewing potential Zocor lawsuits for individuals who have been diagnosed with rhabdomyolysis,… Read More
As a result of an increased risk of muscle injury, myopathy and rhabdomyolysis from Zocor side effects, the FDA is calling for severe limits on the use of the cholesterol drug simvastatin at its highest dose. The product liability lawyers at Saiontz & Kirk, P.A. are… Read More
The FDA released an early communication yesterday about an ongoing safety review of Vytorin, Zetia and Zocor, and a possible association with the development of cancer. Vytorin users were found to have a higher incidence of cancer in a small study that was recently released, and… Read More
Following the release of damaging data about their blockbuster cholesterol drugs, Merck and Schering-Plough now face Zetia and Vytorin class action lawsuits from users who claim that the drugs carry no medical benefits over cheaper, generic alternatives. In addition, the FDA issued an early communication late… Read More
According to a study released yesterday, the risk of Zetia and Vytorin side effects could outweigh the potential benefits for many users. Data from a clinical trial indicates that the cholesterol drugs do not provide any medical benefits for users when compared with high doses of… Read More
